Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest IMS Health Stories

2012-09-13 02:26:45

TEANECK, N.J., Sept. 13, 2012 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it has been positioned as a Leader in the IDC Health Insights "IDC MarketScape: Worldwide Pharmaceuticals Social Media Analytics 2012 Vendor Assessment" (document number HI236520, dated August 2012). The IDC MarketScape report evaluated the social media analytics offerings capabilities of leading social media analytics software and services providers to the pharmaceutical industry. The evaluation was...

2012-09-10 22:23:17

ZURICH, September 11, 2012 /PRNewswire/ -- - State-of-the-art facility in Yaroslavl demonstrates Takeda's long-term commitment to the Russian market - Plant expected to be fully operational in 2014, supplying high quality tablet and sterile liquid products for the local market - EUR75 million investment Takeda Pharmaceutical International GmbH ("Takeda") today announced the completion of construction at its pharmaceutical...

2012-08-21 06:27:32

SAO PAULO, Aug. 21, 2012 /PRNewswire/ -- Leading events organiser, UBM Live, announced today at the opening of CPhI South America 2012 that it plans to expand its offering in 2013 to better serve ingredients buyers in the South American market. The expansion includes the co-location of CPhI South America, South America's leading pharmaceutical networking events, with Food Ingredients South America (FiSA), South America's leading food ingredients networking event, bringing together the two...

2012-08-06 02:25:37

PITTSBURGH, Aug. 6, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Etomidate Injection USP, 2 mg/mL packaged in 40 mg/20 mL single-use vials. This product is the generic version of Hospira's Amidate(®) Injection, which is indicated by intravenous injection for the induction of general anesthesia. Etomidate...

2012-08-02 23:02:44

The American health care system saved more than $1 trillion through the use of generic medicines over the last decade, according to a new study released by the Generic Pharmaceutical Association (GPhA). The analysis conducted by IMS Health highlights the value of generic medications and serves as a reminder of the powerful ways that pharmacy benefit managers (PBMs) increase generic utilization, the Pharmaceutical Care Management Association (PCMA) said today. Washington, DC (PRWEB) August...

2012-08-02 06:20:25

DEARBORN, Mich., Aug. 2, 2012 /PRNewswire/ -- Drivers of Ford SYNC(®) AppLink((TM))-equipped vehicles now can check allergy, pollen, asthma, flu and UV conditions on the go with the Allergy Alert(®) app Allergy sufferers can check current forecasts using simple voice commands Ford continues in efforts to improve the health and wellness of drivers by utilizing connectivity for more than information and entertainment Allergy Alert(®) app is now compatible with Ford...

2012-06-28 02:27:53

PITTSBURGH, June 28, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Mylan Institutional business has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for preservative-free Thiamine Hydrochloride Injection, 100 mg/mL, packaged in 200 mg/2 mL multiple-dose vials. This product is indicated for the treatment of thiamine deficiency. Thiamine Hydrochloride Injection, 100 mg/mL, had U.S. sales of...

2012-05-23 14:21:30

AMSTERDAM, May 23, 2012 /PRNewswire/ -- Leading events organiser UBM Live today announced details of its annual schedule of China events for the global pharmaceutical market. Set to be hosted from 26th to 28th June at the SNIEC in Shanghai, CPhI China for pharmaceutical ingredients, and ICSE China for contract and outsourced services, will be co-located with BioPh China for the biopharmaceutical sector, InnoPack China for innovative packaging services and solutions, and LABWorld China for...

2012-05-23 06:26:06

PITTSBURGH, May 23, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nevirapine Tablets USP, 200 mg. This product is the generic version of Boehringer Ingelheim's Viramune® and is indicated for combination antiretroviral (ARV) treatment of HIV-1 infection. (1) Mylan CEO Heather Bresch said: "The launch...

2012-04-19 10:25:59

Industry Leader to Play Critical Role in the Accelerated Recovery Initiative WASHINGTON, April 19, 2012 /PRNewswire-USNewswire/ -- The Generic Pharmaceutical Association (GPhA) today announced that it has selected IMS Health to serve as the Independent Third Party (ITP) in the Accelerated Recovery Initiative (ARI) -- the generic industry's unprecedented multi-stakeholder initiative designed to accelerate the recovery of certain critical drugs in short supply to patients in need. IMS --...